发明名称 Heterocyclic compound and use thereof
摘要 <p>Disclosed herein is a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present disclosure is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer’s disease or attention deficit hyperactivity disorder (ADHD) and the like. Embodiments of the compound include the following: 9-(4-phenoxyphenyl)-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide, and 9-[4-(cyclohexyloxy)phenyl]-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide.</p>
申请公布号 NZ607593(A) 申请公布日期 2015.01.30
申请号 NZ20110607593 申请日期 2011.08.09
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 OSAMU UJIKAWA;KORI MASAKUNI;NAKAMURA SHINJI;TOYOFUKU MASASHI;HONDA EIJI;ASANO YASUTOMI;MOCHIZUKI MICHIYO;TOSHIHIRO IMAEDA
分类号 C07D513/04;A61K31/542;A61P25/00 主分类号 C07D513/04
代理机构 代理人
主权项
地址